MNRGX
Price
$47.50
Change
-$0.98 (-2.02%)
Updated
Nov 13 closing price
Net Assets
19.14M
VITSX
Price
$160.62
Change
-$2.87 (-1.76%)
Updated
Nov 13 closing price
Net Assets
2.05T
Interact to see
Advertisement

MNRGX vs VITSX

Header iconMNRGX vs VITSX Comparison
Open Charts MNRGX vs VITSXBanner chart's image
Manor Growth
Price$47.50
Change-$0.98 (-2.02%)
VolumeN/A
Net Assets19.14M
Vanguard Total Stock Market Idx I
Price$160.62
Change-$2.87 (-1.76%)
VolumeN/A
Net Assets2.05T
MNRGX vs VITSX Comparison Chart in %
View a ticker or compare two or three
VS
MNRGX vs. VITSX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MNRGX is a StrongBuy and VITSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VITSX has more cash in the bank: 2.05T vs. MNRGX (19.1M). VITSX pays higher dividends than MNRGX: VITSX (1.12) vs MNRGX (0.00). MNRGX was incepted earlier than VITSX: MNRGX (26 years) vs VITSX (28 years). MNRGX (0.99) is less costly to investors than VITSX (0.03). MNRGX is a more actively managed with annual turnover of: 12.05 vs. VITSX (2.00). MNRGX has a lower initial minimum investment than VITSX: MNRGX (1000) vs VITSX (5000000). VITSX annual gain was more profitable for investors over the last year : 13.43 vs. MNRGX (8.34). VITSX return over 5 years is better than : 84.03 vs. MNRGX (46.75).
MNRGXVITSXMNRGX / VITSX
Total Expense Ratio0.990.033,300%
Annual Report Gross Expense Ratio0.990.033,300%
Fund Existence26 years28 years-
Gain YTD15.59415.98798%
Front LoadN/AN/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets19.1M2.05T0%
Annual Yield % from dividends0.001.12-
Returns for 1 year8.3413.4362%
Returns for 3 years46.5368.2668%
Returns for 5 years46.7584.0356%
Returns for 10 years144.80236.1061%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RIO71.110.79
+1.12%
Rio Tinto plc
ARWR41.42-0.08
-0.19%
Arrowhead Pharmaceuticals
CEPO10.38-0.02
-0.24%
Cantor Equity Partners I Inc
CRI33.21-0.23
-0.69%
Carter's
QNTM8.33-0.28
-3.31%
Quantum Biopharma Ltd